{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-039829","form_type":"8-K","ticker":"SIGA","cik":"0001010086","company_name":"SIGA TECHNOLOGIES INC","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.217161+00:00","generated_at":"2026-06-22T07:35:54.545594+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"SIGA Q3 2022 revenue surges to $72.2M from $4.8M YoY; net income of $33.0M vs loss","bullets":["Q3 2022 total revenues $72.2M, compared to $4.8M in Q3 2021; net income $33.0M ($0.45 diluted EPS).","Nine-month revenues $99.4M (prior year $18.3M); net income $34.7M ($0.47 diluted EPS).","International orders drove ~$61M in Q3 deliveries; through Oct 31, ~$77M orders from 13 customers (12 new).","DoD awarded up to $10.7M new contract (Sep); total 2022 DoD contracts up to $18.1M for oral TPOXX.","BARDA exercised ~$26M procurement option for IV TPOXX (Aug); monkeypox clinical trials initiated in US, UK, DRC."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-039829","json":"https://secwatch.observer/filing/0001140361-22-039829.json","markdown":"https://secwatch.observer/filing/0001140361-22-039829.md","text":"https://secwatch.observer/filing/0001140361-22-039829.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1010086/000114036122039829/0001140361-22-039829-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1010086/000114036122039829/brhc10043715_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T07:35:54.545594+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3e508bb422f98e6b6f085855dfd52d0cf8214a11","claim":"SIGA TECHNOLOGIES INC reported Third Quarter 2022 results: revenue 72.2, net income 33.0, EPS 0.45.","evidence_excerpt":"except per share amounts) Third Quarter 2022 in comparison to Third Quarter 2021 Three Months Ended September 30, 2022 Three Months Ended September 30, 2021 Total Revenues $ 72.2 $ 4.8 Operating Income (Loss) (1) $ 42.9 $ (2.9 ) Income (Loss) before Income Taxes (1) $ 43.1 $ (4.0 ) Net Income (Loss) $ 33.0 $ (3.1 ) Diluted Income (Loss) per Share $ 0.45","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1010086/000114036122039829/0001140361-22-039829-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Third Quarter 2022"},{"label":"Revenue","value":"72.2"},{"label":"Net income","value":"33.0"},{"label":"EPS","value":"0.45"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"af2febd74c3eea2546b1a97db4e3c7e0c060d11b","claim":"SIGA TECHNOLOGIES INC reported Three Months Ended September 30, 2022 results: revenue 72.2, net income 33.0, EPS 0.45.","evidence_excerpt":"Total Revenues $ 72.2 $ 4.8 Operating Income (Loss) (1) $ 42.9 $ (2.9 ) Income (Loss) before Income Taxes (1) $ 43.1 $ (4.0 ) Net Income (Loss) $ 33.0 $ (3.1 ) Diluted Income (Loss) per Share $ 0.45 per share ($0.04) per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1010086/000114036122039829/0001140361-22-039829-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Three Months Ended September 30, 2022"},{"label":"Revenue","value":"72.2"},{"label":"Net income","value":"33.0"},{"label":"EPS","value":"0.45"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}